ClinicalTrials.gg
RecruitingNCT04168866Updated Aug 29, 2025

Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon

An interventional study of Operative management and Drainage or antibiotics in Appendicitis, sponsored by Yale University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by Yale University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2020; still recruiting 6 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators aim to determine if early operative intervention is superior to non-operative management for adult patients with computerized tomography (CT)-proven complicated appendicitis with phlegmon or abscess.

Read the detailed description

Complicated appendicitis with abscess or phlegmon represents a challenging problem to emergency general surgeons, and the preferred treatment remains controversial. A variety of therapies have been recommended including early operative intervention, delayed operative intervention, and non-operative management. Recently, a prospective randomized controlled trial from a single center was conducted in Finland comparing operative and non-operative management of appendiceal abscess. Patients managed in the operative arm were found to have a shorter length of stay, fewer re-admissions, and fewer additional interventions than those managed in the non-operative group, but there is no high-quality randomized control trial conducted in the United States to support this. The investigators, therefore plan to carry out a multi-center, patient choice study comparing operative and non-operative management of complicated appendicitis with abscess or phlegmon in the United States.

02

Conditions studied

  • Appendicitis

Browse trials for

03

In context

Appendicitis

419 studies on the registry are indexed under Appendicitis; 67 are open to participants now.

This study's planned enrollment of 180 is above the median of 111 across 252 interventional studies indexed under Appendicitis.

Browse Appendicitis studies →

Lead sponsor

Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1. Complicated appendicitis with presumed perforation on (computer tomography) CT scan AND phlegmon or abscess greater than 2 centimeter (cm).

Exclusion criteria

Exclusion Criteria:

  1. Antibiotic therapy greater than 24 hours prior to considering for enrollment.
  2. Attempted drainage before randomization
  3. Pregnancy
  4. Antibiotic allergy requiring the use of something other than a beta-lactam or quinolone based therapy.
  5. Previous major intra-abdominal surgery by laparotomy
  6. Hospitalization within 2 weeks of randomization
  7. Presence of septic shock on admission.
  8. Mechanical ventilation
  9. Acute renal failure requiring dialysis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Surgery

    Patients who choose operations will have surgery performed to remove the appendix laparoscopically, through 3 or 4 small incisions. All patients in the operative group will receive standard perioperative antibiotics. They will also have the abscess(es) drained during the same surgery if there is one present. In some cases, the operation may be too difficult to perform laparoscopically, so an open appendectomy will be performed, involving a longer incision to remove the appendix. In some cases, both laparoscopic and open are performed. The surgeon may also choose to remove a section of the intestine with the appendix or perform additional procedures.

    Procedure: Operative management

  • Active comparator
    Non-operative management

    If a patient chooses non-operative management and if an abscess is present and amenable to percutaneous drainage this will be performed. If there is no abscess or it is not amenable to drainage antibiotics alone will be provided.

    Other: Drainage or antibiotics

Interventions

  • ProcedureOperative management

    Surgery for computer tomography (CT)-proven complicated appendicitis with phlegmon or abscess.

  • OtherDrainage or antibiotics

    If an abscess is present and amenable to percutaneous drainage this will be performed. If there is no abscess or it is not amenable to drainage antibiotics alone will be provided.

06

What researchers measure

Primary outcomes

  1. Number of hospital days

    This includes all hospital days during the initial stay and any readmission.

    Time frame: Within 60 days of randomization.

Secondary outcomes

  1. Need for additional intervention for appendicitis

    Percutaneous drainage, unplanned operative intervention.

    Time frame: Within one year of the index admission.

  2. Intra-abdominal abscess

    Time frame: More than 7 days after index admission but within 60 days of randomization.

  3. Failed attempted procedure.

    Conversion from laparoscopic to open surgery, conversion from non-operative to operative management, percutaneous drainage not possible or unsuccessful.

    Time frame: Within 60 days of randomization.

  4. Complications

    Defined by National Surgical Quality Improvement Program criteria.

    Time frame: Within 60 days of randomization.

  5. Number of interventions for abscess

    Time frame: Within 60 days of randomization.

  6. Need for bowel resection.

    Time frame: Within 60 days of randomization.

  7. Need for bowel resection

    Time frame: Within 60 days of randomization.

  8. Occurrence of delayed appendectomy

    Time frame: Within one year of index admission.

  9. Recurrence

    Time frame: Within one year of index admission.

  10. Presence of malignancy in any resected specimen

    Time frame: Within one year of index admission.

  11. Days of disability

    Days away from work or school.

    Time frame: Within 60 days of randomization.

  12. Gastrointestinal (GI) quality of life

    This outcome will be measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptoms Scale. This scale includes 8 subscales of which the investigators will use 6 for a maximum of 41 items, though usually less due to skip logic. Each item is measured on a 5-point scale. Items are summed by subscale and converted to a final score by a computer algorithm. A higher score indicates greater symptom severity and lower quality of life.

    Time frame: 30 days after randomization.

  13. GI quality of life

    This outcome will be measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptoms Scale. This scale includes 8 subscales of which the investigators will use 6 for a maximum of 41 items, though usually less due to skip logic. Each item is measured on a 5-point scale. Items are summed by subscale and converted to a final score by a computer algorithm. A higher score indicates greater symptom severity and lower quality of life.

    Time frame: 60 days after randomization.

  14. GI quality of life

    This outcome will be measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptoms Scale. This scale includes 8 subscales of which the investigators will use 6 for a maximum of 41 items, though usually less due to skip logic. Each item is measured on a 5-point scale. Items are summed by subscale and converted to a final score by a computer algorithm. A higher score indicates greater symptom severity and lower quality of life.

    Time frame: One year after randomization.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Mentula P, Sammalkorpi H, Leppaniemi A. Laparoscopic Surgery or Conservative Treatment for Appendiceal Abscess in Adults? A Randomized Controlled Trial. Ann Surg. 2015 Aug;262(2):237-42. doi: 10.1097/SLA.0000000000001200. PubMed 25775072 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04168866
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Nov 19, 2019
Start date
Mar 11, 2020
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Aug 29, 2025

Study contacts

Kevin Schuster, MD, MPH
Contact
kevin.schuster@yale.edu
203 785 2572

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion